A revision to an important ASTM nanotechnology standard incorporates a large-scale interlaboratory study that took place in 2008. The revised standard, ASTM E2490, Guide for Measurement of Particle Size Distribution of Nanomaterials in Suspension by Photon Correlation Spectroscopy (PCS), is under the jurisdiction of Subcommittee E56.02 on Characterization: Physical, Chemical and Toxicological Properties, part of ASTM International Committee E56 on Nanotechnology.
Nanoparticle delivery of diphtheria toxin-encoding DNA selectively expressed in ovarian cancer cells reduced the burden of ovarian tumors in mice, and researchers expect this therapy could be tested in humans within 18 to 24 months.
Scientistst at Rice describe a method for making odako, bundles of single-walled carbon nanotubes named for the traditional Japanese kites they resemble. It may lead to a way to produce meter-long strands of nanotubes, which by themselves are no wider than a piece of DNA.
Researchers have coaxed Geobacter, the sediment-loving microbe who produce electric current from mud and wastewater, to evolve a new strain. It dramatically increases power output per cell, overall bulk power, and with a thinner biofilm, cuts the time to produce electricity on the electrode.
Recent research into the properties of graphene nanoribbons provides two new reasons for using the material as interconnects in future computer chips. In widths as narrow as 16 nanometers, graphene has a current carrying capacity approximately a thousand times greater than copper - while providing improved thermal conductivity.
Scientists in New York and North Carolina are reporting assembly of the first functioning prototype of an artificial Golgi organelle. That key structure inside cells helps process and package hormones, enzymes, and other substances that allow the body to function normally.
According to a recent article published in the Economic Times, the Government of India has ordered pharmaceutical company Natco Pharma, based in Hyderabad in India, to recall its breast cancer drug Albupax from the market within two weeks.